Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02675946 |
|---|---|
| Brief Title: | CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596) |
| First Submitted : | January 22, 2016 |
| First Submitted that Met QC Criteria : | February 3, 2016 |
| First Posted : | February 5, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | January 11, 2022 |
| Last Update Posted : | January 26, 2022 |